Background/Rationale: Hypertension is the leading cause of death and disability worldwide, accounting for more than one tenth (13%) of the total deaths every year. Hypertension control is still elusive despite its complications (e.g., heart disease, stroke and kidney failure) and advances in treatment. Levels of hypertension awareness and control have increased in Canada over the […]
RxOUTMAP tracks and quantifies the impact of pharmacist management of patients with uncomplicated urinary tract infections. Background Urinary tract infection (UTI) is one of the most common indications for which antibacterial agents are initiated. It is also the 8th most common reason for ambulatory clinic visits and the 5th most common reason for emergency […]
Purpose: To determine if pharmacists in the community improve patient management of lower urinary tract symptoms. Setting: Community pharmacies in Edmonton and surrounding area Participants: Seniors who come to the community pharmacy Design: randomized controlled trial Control group: Pharmacist asks some assessment questions about LUTS Pharmacist determines the baseline scores on the patient questionnaire Pharmacist […]
Your browser does not support the video tag. Lead Investigators Dr. Roopinder Sandhu MD, MPH and Dr. Ross Tsuyuki BSc Pharm, PharmD,MSc Study Sponsor Heart and Stroke Foundation of Canada, Canadian Stroke Prevention Intervention Network (C-SPIN) & University of Alberta Hospital Foundation Central Coordinating Centre EPICORE/SPOR, Department of Medicine, University of Alberta Background Atrial fibrillation […]
The goal of this study is to evaluate quality of life of patients with atrial fibrillation (AF) whose care is managed by a Nurse Practioner (NP) vs. standard cardiologist care.
This study seeks to evaluate the effect of Nurse-Practitioner-led care for people with multiple sclerosis (MS), upon patient levels of depression and anxiety as compared to community neurologist outpatient standard care.
Click HERE to access the RxING Practice Tool. In 2013, the original RxING study, entitled “Pharmacist intervention for glycemic control in the community,” was the first to investigate independent prescribing by pharmacists for diabetes care. Pharmacists systemically identified patients with poor glycemic control, prescribed insulin, and provided intensive education and support to attain adherence. As […]
Click HERE to access the RxIALTA study. Background Cardiovascular disease (CVD) is one of the leading causes of morbidity and mortality worldwide and in Canada accounting for nearly one third of the total deaths in both instances. The majority of CVD cases are caused by modifiable risk factors such as tobacco use, obesity, hypertension, hyperlipidemia, […]
ENGAGE IN PHARMACY PRACTICE (ENACT): A REGISTRY OF PROFESSIONAL ABSTINENCE IN PHARMACY PRACTICE, AS SEEN BY PHARMACY STUDENTS With scope of practice constantly evolving, pharmacists are seeing major changes in their practice (and, presumably their role as primary care providers). However, regulatory changes in scope of practice will not substantiate improved care if pharmacists themselves […]